AXS Studio

Medical Animation: Oncology MOD, MOA 

Prev Next
Previous

Medical Animation: Heart Failure HFrEF

Next medical animation of Targeting PDE4 with topical drugs has been unsuccessful due to the difficulty in crossing the epidermis. A novel formulation of roflumilast facilitates drug delivery to the inflammatory cells of psoriasis. We worked with Arcutis scientists & devised a visual model of roflumilast emulsions. Features: lipid matrix, skin cells, epidermis, dermis, corneocytes, stratum corneum, pharma MOA, pharmaceutical MOA animation, drug MOA, dermatology, plaque psoriasis, pharmacology.

Medical Animation: Plaque Psoriasis MOA

2022 AMI Award winner. Innovative medical animation created to educate HCPs on the role of CARD11-BCL10-MALT1, or CBM, in cancer & introduce the MOA of CBM inhibitor, XL114. An animated schematic explains how CBM bridges B-cell and T-cell receptor signaling to the NF-κB pathway. Molecules were modeled using protein structure data & mapped according to subcellular localization data. MOA animation, mechanism of action, scientific animation, mograph, motion graphics, datavis, pharmacology.

Keywords: Animation, 3D, Voiceovers/Narration, Professional Education, Cell biology / Histology, Molecular Biology, Pharmacology, Oncology, Mechanism of Action (MOA)

Exelixis